NCT Number: NCT04731844
Phase: Phase 2
Trial Summary: To explore the use of curcumin and piperine supplementation at a dose of 4 gram/5mg twice a day in early stage prostate cancer patient undergoing active surveillance or patients on – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): University of Rochester
Acronym:
Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives